Ajmal Nassar

Manipala, KA 576104, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

In silico and in vitro evaluation of risedronate as a DKK1 antagonist: Implications for neuroprotection through DKK1-LRP6 modulation.

In silico and in vitro evaluation of risedronate as a DKK1 antagonist: Implications for neuroprotection through DKK1-LRP6 modulation.

Journal: European journal of pharmacology
Published: March 05, 2026

Senescence as a Central Node in Alzheimer's Disease: Molecular Triggers, Cellular Effectors, and RNA-Based Interventions.

Senescence as a Central Node in Alzheimer's Disease: Molecular Triggers, Cellular Effectors, and RNA-Based Interventions.

Journal: Neurochemical research
Published: July 22, 2025

Substance P mitigates lipopolysaccharide induced cognitive impairment in rats in a dose dependent manner.

Substance P mitigates lipopolysaccharide induced cognitive impairment in rats in a dose dependent manner.

Journal: Neuropeptides
Published: May 23, 2025

Pharmacological inhibition of RE1 silencing transcription factor disrupts SOX2 expression and neurogenesis in human induced pluripotent stem cells derived neuronal models.

Pharmacological inhibition of RE1 silencing transcription factor disrupts SOX2 expression and neurogenesis in human induced pluripotent stem cells derived neuronal models.

Journal: Metabolic brain disease
Published: February 22, 2025

Dopamine agonist Rotigotine mitigates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.

Dopamine agonist Rotigotine mitigates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.

Journal: Metabolic brain disease
Published: May 30, 2024

Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer's Disease.

Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer's Disease.

Journal: Molecular neurobiology
Published: September 27, 2023

Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies.

Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies.

Journal: Molecular neurobiology
Published: March 14, 2023

Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies.

Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies.

Journal: Gene
Published: March 13, 2023

Astrocytic MicroRNAs and Transcription Factors in Alzheimer's Disease and Therapeutic Interventions.

Astrocytic MicroRNAs and Transcription Factors in Alzheimer's Disease and Therapeutic Interventions.

Journal: Cells
Published: November 20, 2022
Showing 1-9 of 9

Last Updated: 09/26/2026